Physician profile
Claire Pomeroy
NPI 1174595078
$2,625,952.93
in general payments reported to CMS, 2019-2025
4 companies · $404K in 2025
The $404K reported for 2025 was more than what 99% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422K · 2020: $359K · 2021: $374K · 2022: $362K · 2023: $346K · 2024: $359K · 2025: $404K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.1M · Travel and Lodging: $30K · Food and Beverage: $6,603 · Gift: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,071,746.31 |
| Travel and Lodging | $30,456.29 |
| Food and Beverage | $6,602.85 |
| Gift | $140.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $1,988,646.46 | 2019-2025 | |
| Becton, Dickinson and Company | $430,648.23 | 2019-2022 | |
| Embecta Corp. | $202,140.00 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $4,518.24 | 2019-2020 |
Research and ownership
$4,312,445.56 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Pomeroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.